Concepedia

Gregory E. Agoston

GE

Statistics

Publications

21

Citations

800

H-Index

18

Active since

1991

Affiliations

National Institute on Drug Abuse(Current)

National Institutes of Health

CASI Pharmaceuticals (United States)

Purdue University West Lafayette

Johns Hopkins University

Gregory E. Agoston is an author at National Institute on Drug Abuse specializing in medicine, pharmacology, and medicinal chemistry.

Publications per year

1991–2010

21

Publications

21

Novel N-Substituted 3α-[Bis(4‘-fluorophenyl)methoxy]tropane Analogues:  Selective Ligands for the Dopamine Transporter

Gregory E. Agoston, Jae H. Wu, Sari Izenwasser et al. · Journal of Medicinal Chemistry · 1997 · 105 citations · Full text

, , +17

Differential Binding of Tropane-Based Photoaffinity Ligands on the Dopamine Transporter

Roxanne A. Vaughan, Gregory E. Agoston, John R. Lever et al. · Journal of Neuroscience · 1999 · 72 citations · Full text

, , +17

Effects of N-Substituted Analogs of Benztropine: Diminished Cocaine-Like Effects in Dopamine Transporter Ligands

Jonathan L. Katz, Theresa Kopajtic, Gregory E. Agoston et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 72 citations

, , +17

Significant antitumor activity <i>in vivo</i> following treatment with the microtubule agent ENMD-1198

Theresa LaVallee, Glenn M. Swartz, Ernest Hamel et al. · Molecular Cancer Therapeutics · 2008 · 67 citations · Full text

, , +16

Further studies of the reinforcing effects of benztropine analogs in rhesus monkeys

William L. Woolverton, Gerald S. Hecht, Gregory E. Agoston et al. · Psychopharmacology · 2001 · 59 citations

, , +10

1–5 of 21